Targeted Drug Delivery to Improve Cancer Therapy, 2nd Edition

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: 30 December 2024 | Viewed by 993

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA
Interests: targeted drug delivery; nanoscale dosage forms; nucleic acid therapeutics; small-molecule drugs; antineoplastics; immunological agents
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Increasing the localization of drugs to hematologic or solid tumor cancer cells by targeted drug delivery holds great promise to improve the treatment of cancer with conventional and nonconventional drugs. Given the broad range of drug types, cancers, and tumor heterogeneities, the successful clinical application of targeted drug delivery will continue to require the preclinical development of multiple drug delivery approaches for selection and further clinical development.

This Special Issue seeks to highlight original research articles and reviews on the preclinical development of targeted drug delivery approaches to improve the pharmacotherapy of cancer with conventional and nonconventional drugs. Research areas include any approaches that improve the treatment of preclinical cancer models with small-molecule (<900 Da) or macromolecule drugs (e.g., biomolecules) (e.g., increase potency and/or efficacy, decrease toxicity) by increasing the localization to the site of action in hematologic cancer cells or solid tumor/tumor-associated cells in primary and/or secondary tumors.

Dr. Joseph Anthoney Vetro
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • local drug delivery
  • systemic drug delivery
  • physical drug delivery
  • passive drug delivery
  • targeted drug delivery
  • nanoscale dosage forms
  • nanomedicine

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers

This special issue is now open for submission.
Back to TopTop